U.S. flag

An official website of the United States government

  • delete

NM_000540.3(RYR1):c.7354C>T (p.Arg2452Trp) AND methoxyflurane response - Toxicity/ADR

Germline classification:
drug response (1 submission)
Review status:
3 stars out of maximum of 4 stars
reviewed by expert panel
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000786629.2

Allele description

NM_000540.3(RYR1):c.7354C>T (p.Arg2452Trp)

Gene:
RYR1:ryanodine receptor 1 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
19q13.2
Genomic location:
Preferred name:
NM_000540.3(RYR1):c.7354C>T (p.Arg2452Trp)
HGVS:
  • NC_000019.10:g.38500636C>T
  • NG_008866.1:g.71937C>T
  • NM_000540.3:c.7354C>TMANE SELECT
  • NM_001042723.2:c.7354C>T
  • NP_000531.2:p.Arg2452Trp
  • NP_000531.2:p.Arg2452Trp
  • NP_001036188.1:p.Arg2452Trp
  • LRG_766t1:c.7354C>T
  • LRG_766:g.71937C>T
  • LRG_766p1:p.Arg2452Trp
  • NC_000019.9:g.38991276C>T
  • NM_000540.2:c.7354C>T
  • NP_000531.2:p.R2452W
  • P21817:p.Arg2452Trp
  • p.(Arg2452Trp)
  • r.(?)
Protein change:
R2452W; ARG2452TRP
Links:
PharmGKB: 1445400172PA164749136; PharmGKB: 1445400172PA449461; PharmGKB: 1445400172PA449845; PharmGKB: 1445400172PA450106; PharmGKB: 1445400172PA450434; PharmGKB: 1445400172PA451341; PharmGKB: 1445400172PA451522; UniProtKB: P21817#VAR_045728; OMIM: 180901.0042; dbSNP: rs118192124
NCBI 1000 Genomes Browser:
rs118192124
Molecular consequence:
  • NM_000540.3:c.7354C>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001042723.2:c.7354C>T - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
methoxyflurane response - Toxicity/ADR
Identifiers:

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000925451PharmGKB
reviewed by expert panel

(Pharmacogenomics knowledge for personalized medicine)
drug response
Condition: methoxyflurane response - Toxicity/ADR
Drug reported used for: Malignant Hyperthermia
germlinecuration

PubMed (7)
[See all records that cite these PMIDs]

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineyesnot providednot providednot providednot providednot providedcuration

Citations

PubMed

Malignant hyperthermia in infancy and identification of novel RYR1 mutation.

Chamley D, Pollock NA, Stowell KM, Brown RL.

Br J Anaesth. 2000 Apr;84(4):500-4.

PubMed [citation]
PMID:
10823104

Mutation screening in the ryanodine receptor 1 gene (RYR1) in patients susceptible to malignant hyperthermia who show definite IVCT results: identification of three novel mutations.

Rueffert H, Olthoff D, Deutrich C, Meinecke CD, Froster UG.

Acta Anaesthesiol Scand. 2002 Jul;46(6):692-8.

PubMed [citation]
PMID:
12059893
See all PubMed Citations (7)

Details of each submission

From PharmGKB, SCV000925451.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedcuration PubMed (7)

Description

PharmGKB Level of Evidence 1A: Annotation for a variant-drug combination in a CPIC or medical society-endorsed PGx guideline, or implemented at a PGRN site or in another major health system.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyesnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Dec 4, 2021